$2.22
-0.02 (-0.89%)
Open$2.25
Previous Close$2.24
Day High$2.25
Day Low$2.15
52W High$21.20
52W Low$1.21
Volume—
Avg Volume949.0K
Market Cap10.31M
P/E Ratio—
EPS$-7.63
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.85M | 7.13M | 6.14M |
| Net Income | -1,263,411 | -1,351,255 | -906,681 |
| Profit Margin | -18.4% | -19.0% | -14.8% |
| EBITDA | -2,085,898 | -2,131,542 | -1,625,986 |
| Free Cash Flow | -871,023 | -1,277,993 | -924,733 |
| Rev Growth | +20.2% | +21.4% | +12.5% |
| Debt/Equity | 0.33 | 0.37 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |